Morgan Adam, a director at Heron Therapeutics, Inc. ($HRTX), made one open market purchase of common shares in the last year, totaling $2.65 million. His most recent buy occurred on August 8, 2025. This places him 257th among nearly 5,000 insiders by purchase value, above the average of $1.46 million across 3.29 transactions per insider. Adam reported no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Director | A | Common Stock | 53960 | $0.00 | 8,877,027.0000 | 183,362,522 | 0.61% | 0.03% |
| Aug. 8, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Director | P | Series A Convertible Preferred Stock | 70012 | $15.00 | 70,012.0000 | 152,329,588 | 9999.99% | 0.05% |
| Aug. 8, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Director | P | Common Stock | 1766546 | $1.50 | 8,823,067.0000 | 152,329,588 | 25.03% | 1.16% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Not found | A | Common Stock | 17950 | $0.00 | 7,056,521.0000 | 0 | 0.26% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Not found | A | Stock Option (Right to Buy) | 35900 | $0.00 | 35,900.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Not found | A | Common Stock | 17950 | $0.00 | 7,056,521.0000 | 0 | 0.26% | 0.00% |
| Jan. 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Not found | A | Stock Option (Right to Buy) | 35900 | $1.73 | 35,900.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Director | A | Stock Option (Right to Buy) | 83685 | $0.00 | 83,685.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Morgan Adam | Director | A | Common Stock | 13948 | $0.00 | 7,038,571.0000 | 0 | 0.20% | 0.00% |